Yes, I will, two doses at the recommended gap.
Recommended by whom?
Pfizer and BioNTech in response have both said their vaccine was tested based on two doses three weeks apart and that they have no data to supportdiverging from that timeline.But given limited supplies, faltering distribution networks and surging infections, many public health experts have argued that spacing the doses further apart can be justified, begging the question: how safe is it?
Andy Pollard, the chief investigator for the Oxford/AstraZeneca trials, said that longer gaps almost always correlated with stronger immune responses and that spacing doses was a common feature of many vaccination strategies. “The idea of having [a longer] gap is absolutely mainstream in immunology,” he said.
Data from the Oxford/AstraZeneca trials supports the new regimen. It showed that antibody levels were nearly three times higher in participants who had waited 12 weeks between doses, compared with those where the gap had been under 6 weeks.